Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer
      Description

      The investigators will test the hypothesis that positron emission tomography (PET) imaging with the imaging agent 18F-thymidine (FLT) can rapidly assess treatment response in patients with unresectable non-small cell lung cancer (NSCLC).

      Conditions
      Non-small Cell Lung CancerStarting Pemetrexed Based TherapyUnresectable Cancer
      Talk to us